United Therapeutics Corporation UTHR
562.02 USD -3.70 (-0.65%)
At closeNov 6, 2026, 4:00 PM EST
562.02 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
559.41 Day range 569.45
444.04 52-week range 614.23
- YTD
- +15.35%
- 1 year
- +23.79%
Held by funds
333 US ETFs and mutual funds hold UTHR · largest positions
Ownership
Held by insiders 2.02%
Held by institutions 100.53%
Float held by institutions 102.60%
Institutions 1,227
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 12.43% | 5,294,529 | 2.98B | Jun 29, 2026 |
| Avoro Capital Advisors LLC | 6.52% | 2,777,777 | 1.56B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.51% | 1,919,429 | 1.08B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.50% | 1,918,256 | 1.08B | Jun 29, 2026 |
| State Street Corporation | 4.46% | 1,898,064 | 1.07B | Jun 29, 2026 |
| Renaissance Technologies, LLC | 4.01% | 1,708,739 | 960.35M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.59% | 1,527,799 | 858.65M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.16% | 1,347,720 | 757.45M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.29% | 973,490 | 547.12M | Jun 29, 2026 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.69% | 719,385 | 404.31M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.14% | 486,555 | 273.45M | Jun 29, 2026 |
| iShares Trust-iShares Biotechnology ETF | 0.76% | 323,432 | 181.78M | Sep 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BENKOWITZ MICHAEL | President | Conversion of Exercise of derivative security | Mar 12, 2026 | 0 |
| CAUSEY CHRISTOPHER | Director | Sale | Mar 29, 2026 | 4,190 |
| EDGEMOND JAMES C. | Chief Financial Officer | Sale | Jun 21, 2026 | 18,876 |
| GILTNER RICHARD A | Director | Conversion of Exercise of derivative security | Jul 8, 2026 | 21,884 |
| KURZWEIL RAYMOND C | Director | Conversion of Exercise of derivative security | Jul 8, 2026 | 13,320 |
| MAHON PAUL A | General Counsel | Sale | Nov 4, 2026 | 45,172 |
